Original article
Diagnostic value of anti-neutrophil cytoplasmic and anti-endothelial cell antibodies in early Kawasaki disease1

https://doi.org/10.1016/S0022-3476(05)83180-4Get rights and content

Objective:

To assess the diagnostic potential of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-endothelial cell antibodies (AECA) to distinguish early Kawasaki disease (KD) from febrile diseases resembling KD.

Design: Case-control study.

Setting: Tertiary care facility.

Patients: Eighteen patients with KD tested within 2 weeks of disease onset and before immune globulin therapy; 20 control children with fever and at least one other KD criterion; 21 children with noninflammatory disorders (patients scheduled for elective surgery, or after trauma).

Methods: We detected ANCA by immunofluorescence and enzyme-linked immunosorbent assay (ELISA), and AECA by a cell-ELISA with fixed human umbilical vein endothelial cells.

Results: We found that 7 of 18 patients with KD and 6 of 20 febrile control patients had ANCA (by immunofluorescence or ELISA, p value not significant); 3 of 18 patients with KD and 8 of 20 febrile control patients had AECA (p value not significant). One of three patients with KD who had aneurysms had ANCA; none had AECA.

Conclusions: The ANCA and AECA tests used in this study did not differentiate early KD from other childhood diseases with which it may be confused.

References (20)

There are more references available in the full text version of this article.

Cited by (42)

  • Kawasaki Disease

    2015, Textbook of Pediatric Rheumatology
  • Kawasaki disease

    2011, Textbook of Pediatric Rheumatology
  • A child with a systemic febrile illness - differential diagnosis and management

    2006, Best Practice and Research: Clinical Rheumatology
    Citation Excerpt :

    There are no specific laboratory tests and the diagnosis is essentially clinical. Anti-neutrophil cytoplasmic antibodies may be present but are not diagnostic as they may also be positive due to infection.13 Intravenous immunoglobulins (2 g/kg) are the treatment of choice and will prevent the development of coronary artery disease if given early.

  • Pathogenic Mechanisms Of Anti-Endothelial Cell Antibodies (AECA): Their Prevalence And Clinical Relevance

    2006, Advances in Clinical Chemistry
    Citation Excerpt :

    However, later studies provided conflicting evidence on the effective role of AECA in KD. Guzman et al. [52] observed AECA in just 17% of 22 patients with KS and AECA were not able to differentiate KD from other febrile disorders of childhood resembling KD. Similar findings were reported by Nash et al. [53] in 58 children with acute KD, which showed no increased AECA reactivity compared to 35 children with febrile infections.

  • Kawasaki disease

    2005, Textbook of Pediatric Rheumatology
View all citing articles on Scopus
1

Supported in part by a grant from British Columbia's Children's Hospital, Vancouver, Canada.

View full text